Evidence map›Paper›PMID 34273918›Full record

ArticleInternational journal of health policy and management2021

Cost-Effectiveness of Population Level and Individual Level Interventions to Combat Non-communicable Disease in Eastern Sub-Saharan Africa and South East Asia: A WHO-CHOICE Analysis.

Melanie Y Bertram, Daniel Chisholm, Rory Watts, Temo Waqanivalu, Vinayak Prasad, Cherian Varghese

Open access · diamondAbstract read
In one paragraph

Article in International journal of health policy and management, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Melanie Y BertramDepartment of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-7641-8943
Daniel ChisholmDepartment of Mental Health and Substance Abuse, World Health Organization, Geneva, Switzerland.ORCID 0000-0002-4114-0961
Rory WattsDepartment of Health Systems Governance and Financing, World Health Organization, Geneva, Switzerland.ORCID 0000-0003-4904-2626
Temo WaqanivaluDepartment of Prevention of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland.ORCID 0000-0003-3946-4913
Vinayak PrasadDepartment of Prevention of Non-Communicable Diseases, World Health Organization, Geneva, Switzerland.ORCID 0000-0001-6961-739X
Cherian VargheseDepartment of Management of Non Communicable Diseases, Violence and Injury, World Health Organization, Geneva, Switzerland.ORCID 0000-0001-6907-0451
World Health Organization · CH

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundTo determine the health system costs and health-related benefits of interventions for the prevention and control of non-communicable diseases (NCDs), including mental health disorders, for the purpose of identifying the most cost-effective intervention options in support of global normative guidance on the best-buy interventions for NCDs. In addition, tools are developed to allow country contextualisation of the analyses to support local priority setting exercises.

methodsThis analysis follows the standard WHO-CHOICE (World Health Organization-Choosing Interventions that are Cost-Effective) approach to generalized cost-effectiveness analysis applied to two regions, Eastern sub-Saharan Africa and South-East Asia. The scope of the analysis is all NCD and mental health interventions included in WHO guidelines or guidance documents for which the health impact of the intervention is able to be identified and attributed. Costs are measured in 2010 international dollars, and benefits modelled beginning in 2010, both for a period of 100 years.

resultsThere are many interventions for NCD prevention and management that are highly cost-effective, generating one year of healthy life for less than Int. $100. These interventions include tobacco and alcohol control policies such as taxation, voluntary and legislative actions to reduce sodium intake, mass media campaigns for reducing physical activity, and treatment options for cardiovascular disease (CVD), cervical cancer and epilepsy. In addition a number of interventions fall just outside this range, including breast cancer, depression and chronic lung disease treatment.

conclusionInterventions that represent good value for money, are technically feasible and are delivered for a low per-capita cost, are available to address the rapid rise in NCDs in low- and middle-income countries. This paper also describes a tool to support countries in developing NCD action plans.

Indexed as

Noncommunicable DiseasesAfrica South of the SaharaAsia, EasternCost-Benefit AnalysisFemaleHumansWorld Health OrganizationBest-BuysCost-Effectiveness AnalysisEconomic EvaluationMental HealthNCDNon-communicable Disease

Identifiers

PMID34273918
PMCPMC9278376
OpenAlexW3183954848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.